Antibody against human insulin-like growth factor
    8.
    发明授权
    Antibody against human insulin-like growth factor 有权
    抗人类胰岛素样生长因子的抗体

    公开(公告)号:US07438911B2

    公开(公告)日:2008-10-21

    申请号:US10513148

    申请日:2003-04-30

    摘要: For the effective treatment of diseases such as cancer in which hIGF participates, there have been desired to be developed antibodies which strongly bind to both factors hIGF-I and hIGF-II and inhibit their functions and fragments of these antibodies. The present invention provides antibodies which have the ability to specifically bind to human IGF-I and IGF-II to thereby inhibit the functions of human IGF-I and IGF-II and have binding activity with a binding constant of 5×109 M−1 or more measured with a biosensor BIACORE. In addition, the present invention provides diagnostics, preventives and remedies for an hIGF-mediated disease and a disease showing pathological progressing due to abnormally promoted hIGF production, which use said antibodies.

    摘要翻译: 为了有效治疗诸如hIGF参与的癌症的疾病,期望开发出与hIGF-1和hIGF-II两者强烈结合并抑制其功能和这些抗体片段的抗体。 本发明提供具有特异性结合人IGF-I和IGF-II从而抑制人IGF-I和IGF-II的功能并具有结合常数为5×10 9的结合活性的抗体, 或者用生物传感器BIACORE测量的更高/更高。 此外,本发明提供了hIGF介导的疾病的诊断,预防措施和补救措施以及由于异常促进的hIGF产生导致使用所述抗体的病理进展的疾病。

    Anti-fibroblast growth factor-8 monoclonal antibody
    9.
    发明授权
    Anti-fibroblast growth factor-8 monoclonal antibody 失效
    抗成纤维细胞生长因子-8单克隆抗体

    公开(公告)号:US06310184B1

    公开(公告)日:2001-10-30

    申请号:US09326590

    申请日:1999-06-07

    IPC分类号: C07K1600

    摘要: Described is a monoclonal antibody capable of specifically binding to fibroblast growth factor-8 (FGF-8) which is related to growth factors of hormone-dependent tumor cells such as prostatic cancer and breast cancer, and inhibits the FGF-8 activity. The monoclonal antibody is useful in analyzing the role and biological function of FGF-8 in hormone-dependent tumor cells such as prostatic cancer and breast cancer and can be beneficial in the treatment of these cancers.

    摘要翻译: 描述了能够特异性结合成纤维细胞生长因子-8(FGF-8)的单克隆抗体,其与激素依赖性肿瘤细胞如前列腺癌和乳腺癌的生长因子相关,并且抑制FGF-8活性。 单克隆抗体可用于分析FGF-8在激素依赖性肿瘤细胞如前列腺癌和乳腺癌中的作用和生物学功能,可有助于治疗这些癌症。